Kent Duncan is a Principal Scientist at Evotec since August 2021, specializing in biotechnology and RNA drug discovery. Prior to this role, Kent served as a Group Leader at the Center for Molecular Neurobiology in Hamburg from January 2010 to July 2021. Kent's earlier experience includes a position as a Postdoctoral Scientist at EMBL from 2002 to 2010 and as a PhD Student at UCSF from 1994 to 2001, where Kent earned a PhD in Biochemistry.
This person is not in any teams
This person is not in any offices